
Vyvanse
Lisdexamfetamine Dimesylate
- SKU
- 59417-115
- Mfr
- Takeda Pharmaceuticals America, Inc.
100 tablet, chewable in 1 bottle
$1,667.99
Price for one pack
Controlled medicine — prescription required. Upload your prescription at checkout or email it to us after ordering. We ship once a pharmacist has checked it and confirmed it with your prescriber. How it works
1) ]. 4 ) VYVANSE is not indicated for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. VYVANSE is not indicated or recommended for weight loss.
- Strength
- Lisdexamfetamine Dimesylate 10 mg/1
- Unit of measure
- Per 1 tablet
- Dosage form
- Tablet, Chewable
- Route
- Oral
Pharmacologic class
- Central Nervous System StimulantEstablished class
- Central Nervous System StimulationPhysiologic effect
- Brand name
- Vyvanse
- Generic name
- Lisdexamfetamine Dimesylate
- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Product NDC (SKU)
- 59417-115
- Active ingredients
- Lisdexamfetamine Dimesylate 10 mg/1
- Unit of measure
- Per 1 tablet
- Dosage form
- Tablet, Chewable
- Route
- Oral
- DEA schedule
- CII
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application number
- NDA208510
- Marketed since
- January 28, 2017
- Label revised
- April 30, 2026
| Package NDC | Description |
|---|---|
| 59417-115-01 | 100 TABLET, CHEWABLE in 1 BOTTLE |
Reading this NDC
59417-115-01
- 01Labeler code
- Takeda Pharmaceuticals America, Inc.
- 02Product code
- Vyvanse, tablet, chewable
- 03Package code
- 100 tablet, chewable in 1 bottle
Lisdexamfetamine is a prodrug of dextroamphetamine. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. The exact mode of therapeutic action in ADHD and BED is not known.
Warning: Abuse, misuse, and addiction
VYVANSE has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including VYVANSE, can result in overdose and death [see Overdosage
], and this risk is increased with higher doses or unapproved methods of administration, such as snorting or injection. Before prescribing VYVANSE, assess each patient's risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout VYVANSE treatment, reassess each patient's risk of abuse, misuse, and addiction and frequently monitor for signs and symptoms of abuse, misuse, and addiction [see Warnings and Precautions
, Drug Abuse and Dependence
]. WARNING: ABUSE, MISUSE, AND ADDICTION See full prescribing information for complete boxed warning. VYVANSE has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including VYVANSE, can result in overdose and death: Before prescribing VYVANSE, assess each patient's risk for abuse, misuse, and addiction.
Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout treatment, reassess each patient's risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.
VYVANSE ® is indicated for the treatment of: Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older [see Clinical Studies
]. Moderate to severe binge eating disorder (BED) in adults [see Clinical Studies
]. VYVANSE is a central nervous system (CNS) stimulant indicated for the treatment of: Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older Moderate to severe binge eating disorder (BED) in adults Limitations of Use: The use of VYVANSE is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage
VYVANSE is not indicated for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of VYVANSE for the treatment of obesity have not been established
Limitations of Use. The use of VYVANSE is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions
, Use in Specific Populations
]. VYVANSE is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of VYVANSE for the treatment of obesity have not been established [see Warnings and Precautions
].
Read before you order

ADHD · 2 min read
ADHD medication: stimulants vs non-stimulants
How methylphenidate, amphetamines, lisdexamfetamine, atomoxetine, guanfacine and viloxazine work, and how doctors choose between them.

ADHD · 2 min read
Living with ADHD medication side effects
Practical ways to handle reduced appetite, poor sleep and the afternoon crash on ADHD medicine, and when to call your doctor.

ADHD · 2 min read
ADHD medication in adults: what is different
Adult ADHD is often diagnosed late. Here is how treatment works for adults, including heart checks, interactions and alcohol.
More in ADHD
View all
Brand · Capsule
Adderall XR
Dextroamphetamine Sulfate 1.25 mg/1, Dextroamphetamine Saccharate 1.25 mg/1, Amphetamine Aspartate Monohydrate 1.25 mg/1, Amphetamine Sulfate 1.25 mg/1
- SKU
- 54092-381
- Mfr
- Takeda Pharmaceuticals America, Inc.
From $922.99Prescription required

Brand · Solution
Arynta
Lisdexamfetamine Dimesylate 10 mg/mL
- SKU
- 24338-019
- Mfr
- Azurity Pharmaceuticals, Inc.
From $1,100.00Prescription required

Generic · Capsule
Atomoxetine
Atomoxetine Hydrochloride 40 mg/1
- SKU
- 0904-6908
- Mfr
- Major Pharmaceuticals
From $18.99Min. 16 packs

Generic · Capsule
Atomoxetine
Atomoxetine Hydrochloride 40 mg/1
- SKU
- 71335-3033
- Mfr
- Bryant Ranch Prepack
From $18.99Min. 16 packs